Ubrolexin Boehringer Ingelheim

Ubrolexin Boehringer Ingelheim – product information

Ubrolexin® intramammary suspension for lactating dairy cows

Each tube contains:

Cefalexin (as monohydrate): 200 mg

Kanamycin (as monosulphate): 100,000 I.U.


Treatment of clinical mastitis in lactating dairy cows for bacteria susceptible to the combination of cefalexin and kanamycin such as Staphylococcus aureus, Streptococcus dysgalactiae, Streptococcus uberis and Escherichia coli.

Dosage & Administration

Treat the infected quarter(s) twice, leaving an interval of 24 hours between treatments.

Related Projects